Milton H. Werner - Net Worth and Insider Trading

Milton H. Werner Net Worth

The estimated net worth of Milton H. Werner is at least $2 Million dollars as of 2024-05-26. Milton H. Werner is the President and CEO, 10% Owner of Inhibikase Therapeutics Inc and owns about 889,241 shares of Inhibikase Therapeutics Inc (IKT) stock worth over $2 Million. Details can be seen in Milton H. Werner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Milton H. Werner has not made any transactions after 2022-08-16 and currently still holds the listed stock(s).

Transaction Summary of Milton H. Werner

To

Milton H. Werner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Milton H. Werner owns 1 companies in total, including Inhibikase Therapeutics Inc (IKT) .

Click here to see the complete history of Milton H. Werner’s form 4 insider trades.

Insider Ownership Summary of Milton H. Werner

Ticker Comapny Transaction Date Type of Owner
IKT Inhibikase Therapeutics Inc 2022-08-16 director & 10 percent owner & President and CEO

Milton H. Werner Latest Holdings Summary

Milton H. Werner currently owns a total of 1 stock. Milton H. Werner owns 889,241 shares of Inhibikase Therapeutics Inc (IKT) as of August 16, 2022, with a value of $2 Million.

Latest Holdings of Milton H. Werner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IKT Inhibikase Therapeutics Inc 2022-08-16 889,241 1.81 1,609,526

Holding Weightings of Milton H. Werner


Milton H. Werner Form 4 Trading Tracker

According to the SEC Form 4 filings, Milton H. Werner has made a total of 4 transactions in Inhibikase Therapeutics Inc (IKT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Inhibikase Therapeutics Inc is the acquisition of 833 shares on August 16, 2022, which cost Milton H. Werner around $4,000.

Insider Trading History of Milton H. Werner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Milton H. Werner Trading Performance

GuruFocus tracks the stock performance after each of Milton H. Werner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Milton H. Werner is -11.16%. GuruFocus also compares Milton H. Werner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Milton H. Werner within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Milton H. Werner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Milton H. Werner

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.26
Relative Return to S&P 500(%) 14.14

Milton H. Werner Ownership Network

Ownership Network List of Milton H. Werner

No Data

Ownership Network Relation of Milton H. Werner


Milton H. Werner Owned Company Details

What does Inhibikase Therapeutics Inc do?

Who are the key executives at Inhibikase Therapeutics Inc?

Milton H. Werner is the director & 10 percent owner & President and CEO of Inhibikase Therapeutics Inc. Other key executives at Inhibikase Therapeutics Inc include Cheif Financial Officer Joseph Frattaroli , and 10 percent owner Daniel Kalman .

Inhibikase Therapeutics Inc (IKT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inhibikase Therapeutics Inc (IKT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibikase Therapeutics Inc (IKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inhibikase Therapeutics Inc (IKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibikase Therapeutics Inc Insider Transactions

No Available Data

Milton H. Werner Mailing Address

Above is the net worth, insider trading, and ownership report for Milton H. Werner. You might contact Milton H. Werner via mailing address: 3350 Riverwood Parkway Se, Suite 1900, Atlanta Ga 30339.

Discussions on Milton H. Werner

No discussions yet.